Tumor inhibitory effect of gefitinib (ZD
β
Daisuke Takabatake; Takeo Fujita; Tadahiko Shien; Kensuke Kawasaki; Naruto Taira
π
Article
π
2006
π
John Wiley and Sons
π
French
β 588 KB
## Abstract Some kinds of breast cancer cell lines, similar to several types of solid tumors, express epidermal growth factor receptor (EGFR). However, gefitinib, an EGFR tyrosine kinase inhibitor, is not effective for all these cell lines. Similarly, taxane is effective for many of the cell lines,